NEILEE WOOD: Open Payments
NPI 1487191946 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,206 in 37 payments from 14 companies in 2025. Trend: 2023 $518 · 2024 $719 · 2025 $1,206
Food & beverage: $1,206
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 5 | $217 |
| AstraZeneca Pharmaceuticals LP | 5 | $201 |
| HISTOSONICS, INC. | 1 | $135 |
| Caris MPI, Inc. | 2 | $117 |
| PFIZER INC. | 1 | $86 |
| Merck Sharp & Dohme LLC | 3 | $84 |
| Exelixis Inc. | 4 | $81 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
Products named: ZYNYZ, BRAFTOVI, MI CANCER SEEK, KEYTRUDA, CABOMETYX, LUTATHERA, FRUZAQLA, Stivarga.
Industry payments across OK — which companies pay providers there.
